ClinicalTrials.Veeva

Menu

Role of Subsequent Atrial Tachycardia in Mechanisms of Persistent AF

J

Johannes Gutenberg University (JGU)

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Procedure: Catheter ablation of subsequent atrial tachycardia

Study type

Observational

Funder types

Other

Identifiers

NCT01896570
Ciritical endpoint HH

Details and patient eligibility

About

In this study, the investigators aim to examine the prognostic role of subsequent Atrial Tachycardias (ATs) in the mechanisms of atrial fibrillation (AF). Therefore, the investigators compare patients who were randomly assigned to either undergo cardioversion after AF has been terminated to AT or further ablation until the achievement of sinus rhythm.

Enrollment

110 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • persistent AF for at least 1 months,
  • age > 18 years,
  • refractory to drug therapy,
  • no prior ablation

Exclusion criteria

  • prior AF ablation

Trial design

110 participants in 2 patient groups

Group A: cardioversion at AT
Description:
after achievement of AT, pts were cardioverted
Group B: ablation to SR
Description:
After AT has been achieved, all subsequent AT were ablated with the endpoint of procedural SR termination
Treatment:
Procedure: Catheter ablation of subsequent atrial tachycardia

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems